METABOMED
Metabomed designs drugs designed treats cancer. Its drugs target the reprogrammed cancer cell's metabolism to halt their growth, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.
METABOMED
Industry:
Biopharma Biotechnology Health Care Life Science Medical
Founded:
2014-01-01
Address:
Yavne, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.metabomed.com
Total Employee:
1+
Status:
Active
Total Funding:
30.5 M USD
Technology used in webpage:
Microsoft Azure DNS ASP.NET IIS ASP.NET 4.0 IIS 8 Hetzner Adobe Enterprise Cloud Symantec.cloud Entrust SSL Adobe Sign
Similar Organizations
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Current Advisors List
Current Employees Featured
Founder
Investors List
Arkin Bio Ventures
Arkin Bio Ventures investment in Series B - Metabomed
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Metabomed
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Metabomed
Yonjin Venture
Yonjin Venture investment in Series B - Metabomed
Pontifax
Pontifax investment in Series B - Metabomed
Arkin Holdings
Arkin Holdings investment in Series A - Metabomed
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Metabomed
M Ventures
M Ventures investment in Series A - Metabomed
Pontifax
Pontifax investment in Series A - Metabomed
Pfizer
Pfizer investment in Series A - Metabomed
Official Site Inspections
http://www.metabomed.com
- Host name: mail.cloudhost.co.il
- IP address: 192.117.187.254
- Location: Tel Aviv Israel
- Latitude: 32.0678
- Longitude: 34.7647
- Timezone: Asia/Jerusalem
More informations about "Metabomed"
Metabomed - Crunchbase Company Profile & Funding
Metabomed designs drugs designed treats cancer. Its drugs target the reprogrammed cancer cell's metabolism to halt their growth, enabling patients to begin their treatment more quickly …See details»
Metabomed Ltd. - Org Chart, Teams, Culture & Jobs - The Org
View Metabomed Ltd.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Metabomed Ltd. - LinkedIn
Metabomed is a drug discovery company in the field of cancer metabolism. The Company is developing a proprietary target identification platform based on computational biology, genomics and ...See details»
Metabomed 2025 Company Profile: Valuation, Funding
Metabomed General Information Description. Operator of a drug discovery company intended to assist in the field of cancer metabolism. The company's proprietary target identification …See details»
Metabomed Company Profile - Office Locations, Competitors
Sep 9, 2020 Metabomed is a drug discovery company in the field of cancer metabolism. The Company is developing a proprietary target identification platform based on computational …See details»
Metabomed Ltd.: Contact Details and Business Profile
Metabomed is a drug discovery company in the field of cancer metabolism. The Company is developing a proprietary target identification platform based on computational biology, …See details»
METABOMED INC. Company Profile | Cambridge, MA
Find company research, competitor information, contact details & financial data for METABOMED INC. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Metabomed LTD: Revenue, Worth, Valuation & Competitors 2024
About Metabomed LTD. Metabomed LTD is a Biotech related company founded in 2014 with an estimated revenue of $930K, and 6 employees. It has 10 competitors including Dermavant …See details»
Metabomed Ltd. - VentureRadar
Metabomed Ltd., is an Israeli based newly created biotech company focused on the identifications of novel targets in the field of cancer metabolism. Based on its proprietary interdisciplinary …See details»
Metabomed - Israeli Startup | Startup Nation Finder
Apr 4, 2016 Metabomed is a drug-discovery company in the field of cancer metabolism, with a proprietary target-identification platform based on computational biology and metabolomics. …See details»
Cancer Metabolism Company Metabomed Completes $18 Million …
Yavne, Israel 4 April, 2016– Israeli cancer metabolism company Metabomed LTD. announced today that it has completed an extension of its Series A round from current and new investors …See details»
Metabomed Ltd. - BioCentury Company Profiles - BCIQ
Metabomed Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Metabomed Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Metabomed Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule drug, Unknown, Enzyme, …See details»
Cancer Metabolism Company Metabomed Completes $18 Million …
Metabomed and its technology, and I am very honored to have been chosen to lead the ... the Merck organization. For more information, please visit www.ms-ventures.com. About …See details»
Metabomed | LinkedIn
Metabomed is a drug discovery company in the field of cancer metabolism. The Company is developing a proprietary target identification platform based on computational biology, …See details»
Metabomed - F6S
Metabomed is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed …See details»
Metabomed Ltd. - VentureRadar
Metabomed is developing a therapeutic strategy based on new drugs that inhibit metabolic enzymes which are vital for cancer cells’ survival. Metabomed identifies reprogrammed …See details»
Metabomed Completes a $12.5 Million Raise in Order to Advance …
Dec 19, 2019 YAVNE, Israel and CAMBRIDGE, Massachusetts, Dec. 19, 2019 /PRNewswire/ -- Metabomed, a leading cancer metabolism company completed a financing of $12.5 million …See details»
META BIOMED
Dental. Meta Biomed Dental Business Department is a leading Korean company in the dental equipment and materials industry and has been selling our products to about 110 countries for …See details»
Exploring ICU nurses’ response to alarm management and …
Apr 11, 2025 Background Alarm fatigue is a critical issue in intensive care units, negatively impacting nurse well-being and patient safety. Understanding nurses’ experiences and …See details»